Celldex Therapeutics (CLDX) Payables (2010 - 2026)
Celldex Therapeutics' Payables came in at $14.68 million for Q2 2026, up 607.9% from $2.07 million a year earlier and up 41.7% from the prior quarter.
Powered by 
Analysis
Celldex Therapeutics (CLDX) Payables (2010 - 2026) Analysis & Trends
At the end of FY2025, Celldex Therapeutics' Payables was $1.18 million, down 63.9% from FY2024.
- Payables carries a five-year compound annual growth rate of 2.4% (FY2020 to FY2025).
- Going back by year, Payables was $3.27 million in FY2024 (-6.6%), $3.49 million in FY2023 (+4.6%), $3.34 million in FY2022 (+172.0%) and $1.23 million in FY2021 (+17.2%).
- The Q2 2026 figure represents the highest quarterly Payables in data going back to Q4 2010.
- Year-over-year, Payables increased in four of the last eight quarters, with growth averaging 114.4%.
- The fastest year-over-year change in Payables over five years came in Q2 2026 (growth of 607.9%), and the weakest in Q3 2024 (a decline of 68.9%).
- Business Quant data shows CLDX's Payables at $10.36 million (Q1 2026), $1.18 million (Q4 2025) and $4.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 20.92 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 5.96 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 7.03 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Celldex Therapeutics | 2.47 Bn | 2.47 Bn | - | 14.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.68 Mn |
| Mar 31, 2026 | 10.36 Mn |
| Dec 31, 2025 | 1.18 Mn |
| Sep 30, 2025 | 4.27 Mn |
| Jun 30, 2025 | 2.07 Mn |
| Mar 31, 2025 | 3.41 Mn |
| Dec 31, 2024 | 3.27 Mn |
| Sep 30, 2024 | 1.11 Mn |
| Jun 30, 2024 | 3.80 Mn |
| Mar 31, 2024 | 3.23 Mn |
| Dec 31, 2023 | 3.49 Mn |
| Sep 30, 2023 | 3.59 Mn |
| Jun 30, 2023 | 881,000.00 |
| Mar 31, 2023 | 3.37 Mn |
| Dec 31, 2022 | 3.34 Mn |
| Sep 30, 2022 | 2.27 Mn |
| Jun 30, 2022 | 902,000.00 |
| Mar 31, 2022 | 1.02 Mn |
| Dec 31, 2021 | 1.23 Mn |
| Sep 30, 2021 | 836,000.00 |
API Access
Celldex Therapeutics Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CLDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CLDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CLDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();